Skip to main content
logo
Sandoz Group AG (SWX:SDZ)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
65.76
-1.60 (-2.38%)
Jul 31, 2026, 5:30 PM CET

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Biosimilars Revenue
3.47B3.29B2.85B
Generics Revenue
7.89B7.79B7.50B
Revenue (Other)
-71.00M27.00M
Revenue (Total)
-11.16B10.38B

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Europe Revenue
6.12B5.94B5.36B
International Revenue
2.73B2.71B2.56B
North America Revenue
2.51B2.44B2.44B
Revenue (Other)
-71.00M27.00M
Revenue (Total)
-11.16B10.38B

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Biosimilars - Net Sales Growth in Constant Currency
15.00%30.00%
Generics - Net Sales Growth in Constant Currency
4.00%2.00%
Europe - Net Sales Growth in Constant Currency
11.00%6.00%
International - Net Sales Growth in Constant Currency
6.00%8.00%
North America - Net Sales Growth in Constant Currency
-15.00%
Total Net Sales Growth in Constant Currency
7.00%9.00%
Number of Patients Treated
873.00M902.00M